237 related articles for article (PubMed ID: 20810247)
1. Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.
Silva F; Hummel AM; Jenne DE; Specks U
J Autoimmun; 2010 Dec; 35(4):299-308. PubMed ID: 20810247
[TBL] [Abstract][Full Text] [Related]
2. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.
Van Der Geld YM; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1999 Dec; 118(3):487-96. PubMed ID: 10594572
[TBL] [Abstract][Full Text] [Related]
4. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
6. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
7. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.
Sun J; Fass DN; Viss MA; Hummel AM; Tang H; Homburger HA; Specks U
Clin Exp Immunol; 1998 Nov; 114(2):320-6. PubMed ID: 9822293
[TBL] [Abstract][Full Text] [Related]
8. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
Front Immunol; 2020; 11():573040. PubMed ID: 33101296
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis.
Bruner BF; Vista ES; Wynn DM; Harley JB; James JA
Clin Exp Immunol; 2010 Nov; 162(2):262-70. PubMed ID: 21077276
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.
Selga D; Segelmark M; Wieslander J; Gunnarsson L; Hellmark T
Clin Exp Immunol; 2004 Jan; 135(1):164-72. PubMed ID: 14678279
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis.
Hinkofer LC; Hummel AM; Stone JH; Hoffman GS; Merkel PA; Spiera ER; St Clair W; McCune JW; Davis JC; Specks U; Jenne DE
J Autoimmun; 2015 May; 59():43-52. PubMed ID: 25744251
[TBL] [Abstract][Full Text] [Related]
12. Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology.
Rarok AA; van der Geld YM; Stegeman CA; Limburg PC; Kallenberg CG
J Clin Immunol; 2003 Nov; 23(6):460-8. PubMed ID: 15031633
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
[TBL] [Abstract][Full Text] [Related]
14. A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein.
Farrag L; Pendergraft WF; Yang JJ; Jennette JC; Falk RJ; Preston GA
Autoimmunity; 2007 Nov; 40(7):503-11. PubMed ID: 17966040
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.
Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears A; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S45-52. PubMed ID: 19646346
[TBL] [Abstract][Full Text] [Related]
16. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
Granel J; Korkmaz B; Nouar D; Weiss SAI; Jenne DE; Lemoine R; Hoarau C
Front Immunol; 2021; 12():571933. PubMed ID: 33679731
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis.
Feng Z; Liu P; Li Z; Sui B
J Clin Lab Anal; 2008; 22(1):73-6. PubMed ID: 18200577
[TBL] [Abstract][Full Text] [Related]
19. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells.
Van der Geld YM; Smook ML; Huitema MG; Harmsen MC; Limburg PC; Kallenberg CG
J Immunol Methods; 2002 Jun; 264(1-2):195-205. PubMed ID: 12191522
[TBL] [Abstract][Full Text] [Related]
20. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]